Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: An Open Label, Dose Escalation Study With A Double Blind Randomised Placebo Controlled Withdrawal To Examine The Effects Of The Histamine H3 Antagonist GSK189254 In Patients With
Brief Summary: The purpose of this study is to assess the effectiveness and safety of the drug GSK189254 in treating patients with narcolepsy.